Fenofibrate Monotherapy Induced Rhabdomyolysis
- 1 August 2003
- journal article
- Published by American Diabetes Association in Diabetes Care
- Vol. 26 (8) , 2482-2483
- https://doi.org/10.2337/diacare.26.8.2482
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Fenofibrate or Gemfibrozil for Treatment of Types IIa and IIb Primary Hyperlipoproteinemia: A Randomized, Double-Blind, Crossover StudyEndocrine Practice, 2002
- Increasing high-density lipoprotein cholesterol: an update on fenofibrateThe American Journal of Cardiology, 2001
- Effect of fenofibrate on progression of coronary-artery disease in type 2 diabetes: the Diabetes Atherosclerosis Intervention Study, a randomised studyThe Lancet, 2001
- Long-Term Efficacy and Safety of Fenofibrate and a Statin in the Treatment of Combined HyperlipidemiaThe American Journal of Cardiology, 1998
- Fenofibrate, a third-generation fibric acid derivativeThe American Journal of Medicine, 1987
- Malignancy following treatment of rheumatoid arthritis with cyclophosphamideThe American Journal of Medicine, 1987